Ikena Oncology Inc.
13F holders, Q2 2025 (June 30)At the end of Q2 2025, 41 institutions reported holding Ikena Oncology Inc. in their 13F filings, down 5 from Q1 2025. 4 opened new positions and 9 sold out. The largest holders were Atlas Venture Life Science Advisors, LLC ($6.7M), Blue Owl Capital Holdings LP ($5.5M) and BML Capital Management, LLC ($5.4M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Ikena Oncology Inc.
- CUSIP
- 45175G108
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $42K |
| Exits | 9 | $635K |
All 13F filers, Q1 2025 → Q2 2025: 506,062 shares bought and 1,491,906 shares sold, net −985,844 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 41 holders
| Atlas Venture Life Science Advisors, LLC | 1.02% | No change | 5,018,178 | $6.7M |
| Blue Owl Capital Holdings LP | 1.78% | No change | 4,091,118 | $5.5M |
| BML Capital Management, LLC | 4.14% | Add +8.6% | 4,030,102 | $5.4M |
| BVF Inc. | 0.19% | No change | 4,006,564 | $5.4M |
| Orbimed Advisors LLC | 0.12% | No change | 3,539,358 | $4.7M |
| Deep Track Capital, LP | 0.11% | No change | 2,515,513 | $3.4M |
| Omega Fund Management, LLC | 1.95% | No change | 2,249,123 | $3.0M |
| Vanguard Group Inc. | 0.00% | Add +2.2% | 1,413,649 | $1.9M |
| Adage Capital Partners Gp, L.L.C. | 0.00% | No change | 800,000 | $1.1M |
| NEA Management Company, LLC | 0.06% | No change | 600,063 | $804K |
| Sofinnova Investments, Inc. | 0.03% | No change | 382,616 | $513K |
| BlackRock, Inc. | 0.00% | Add +2.7% | 357,936 | $480K |
| Gilead Sciences, Inc. | 0.04% | Reduce -69.9% | 348,534 | $467K |
| Renaissance Technologies | 0.00% | Add +4.9% | 308,856 | $414K |
| Geode Capital Management, LLC | 0.00% | Reduce -2.9% | 307,972 | $413K |
| Aldebaran Capital, LLC | 0.32% | Reduce -2.3% | 242,116 | $324K |
| Acadian Asset Management LLC | 0.00% | No change | 209,568 | $278K |
| Jacobs Levy Equity Management, Inc. | 0.00% | Reduce -19.3% | 198,107 | $265K |
| Citadel Advisors | 0.00% | Add +98.5% | 158,215 | $212K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 153,300 | $205K |
| Two Sigma Advisers, LP | 0.00% | Reduce -4.8% | 144,100 | $193K |
| State Street Corp. | 0.00% | No change | 92,153 | $123K |
| Squarepoint Ops LLC | 0.00% | Add +9.4% | 84,680 | $113K |
| UBS Group AG | 0.00% | Reduce -25.8% | 74,661 | $100K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -12.8% | 66,664 | $89K |
| Barclays PLC | 0.00% | No change | 66,177 | $89K |
| Two Sigma Investments, LP | 0.00% | Reduce -25.8% | 58,957 | $79K |
| Northern Trust Corp. | 0.00% | No change | 57,565 | $77K |
| Millennium Management | 0.00% | Reduce -29.2% | 49,315 | $66K |
| Dimensional Fund Advisors LP | 0.00% | No change | 38,621 | $52K |
| Morgan Stanley | 0.00% | Add +118.1% | 27,416 | $37K |
| Berkshire Asset Management LLC | 0.00% | No change | 20,000 | $27K |
| XTX Topco Ltd | 0.00% | Reduce -69.9% | 16,999 | $23K |
| Royal Bank of Canada | 0.00% | New | 16,000 | $21K |
| Susquehanna International Group, LLP | 0.00% | New | 13,141 | $18K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 2,275 | $3K |
| JPMorgan Chase & Co. | 0.00% | No change | 849 | $1K |
| Bank of America Corp. | 0.00% | Add +147.5% | 547 | $733 |
| Wells Fargo & Company | 0.00% | New | 500 | $670 |
| BNP Paribas Financial Markets | 0.00% | No change | 315 | $422 |
| SBI Securities Co., Ltd. | 0.00% | No change | 3 | $4 |
"% of holder's portfolio" is IKENA ONCOLOGY INC's weight in each manager's 13F, not the share of Ikena Oncology Inc. the manager owns.